Correspondence and General Collaboration Papers 2000

Correspondence relating to Infliximab/Remicade, T22 ATTRACT meetings and patents. Also contains copy of patent application “Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Diseases,” 1996.

See SA/KET/A/2/1 for an overview of the Centocor correspondence, general papers and list of main correspondence contributors.

See SA/KET/A/1 for papers on Centocor sponsored clinical studies/trials.

Item contains some duplicate correspondence.

1992-2000

1 file

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment. This item is also restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2061.